Line 302: | Line 302: | ||
<!------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | <!------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ||
− | + | PROJECT OVERVIEW | |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------> | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------> | ||
Line 311: | Line 311: | ||
If you are still working on multiple project ideas by June 30, you may choose one to describe on this form, or you may tell us about other ideas in the "Further Comments" section. | If you are still working on multiple project ideas by June 30, you may choose one to describe on this form, or you may tell us about other ideas in the "Further Comments" section. | ||
</p> | </p> | ||
+ | |||
+ | |||
+ | |||
+ | <!-------------------------------------------------------------------------------------------- Question 11 ---------------------------------------------------------------------------------------------------------> | ||
Line 321: | Line 325: | ||
+ | <!-------------------------------------------------------------------------------------------- Question 12 ---------------------------------------------------------------------------------------------------------> | ||
Line 364: | Line 369: | ||
</ul> | </ul> | ||
+ | |||
+ | |||
+ | <!-------------------------------------------------------------------------------------------- Question 13 ---------------------------------------------------------------------------------------------------------> | ||
+ | |||
+ | |||
+ | |||
+ | <p class="question">13. What safety or ethical risks would be involved with such a use? </p> | ||
+ | |||
+ | <textarea rows="3" name="13. what are the safety ethical risks" data-form-field="safety_ethical_risks"></textarea> | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | <!-------------------------------------------------------------------------------------------- Question 14 ---------------------------------------------------------------------------------------------------------> | ||
+ | |||
+ | |||
+ | <h3> Specific risks </h3> | ||
+ | |||
+ | <p class="question">14. Does your project include the use of gene drives? </p> | ||
+ | |||
+ | <div class="column half_size"> | ||
+ | <ul> | ||
+ | <li><input type="radio" data-form-field="gene drives yes" value="gene_drive_yes"> Yes </label> <br> | ||
+ | STOP: Gene Drives are not allowed in iGEM projects without a special exception from the Safety Committee. For more information see the Safety Policy page and the White List. Please contact the Safety Committee by emailing safety AT igem DOT org | ||
+ | </li> | ||
+ | |||
+ | <li><input type="radio" data-form-field="gene drives no" value="gene_drive_no"> No </label></li> | ||
+ | |||
+ | </ul> | ||
+ | </div> | ||
+ | |||
+ | |||
+ | <div class="column half_size"> | ||
+ | <p>For the purposes of iGEM, a gene drive includes Cas9 (and other endonucleases, such as dCas9 and Cpf1) integrated into the genome (including through the use of gRNA) of a sexually reproducing eukaryotic organisms (including organisms that reproduce both sexually and asexually, such as yeast) and/or the use of a drive to impact the progeny. | ||
+ | |||
+ | </p> | ||
+ | </div> | ||
+ | |||
+ | <div class="clear"></div> | ||
+ | |||
+ | <!-------------------------------------------------------------------------------------------- Question 15 ---------------------------------------------------------------------------------------------------------> | ||
+ | |||
+ | <p class="question">15. Does your project include the use of animals? </p> | ||
+ | |||
+ | |||
+ | <ul> | ||
+ | <li><input type="radio" data-form-field="animal yes" value="animal_yes"> Yes </label> <br> | ||
+ | STOP: The use of animals is not allowed in iGEM projects without a special exception from the Safety Committee. For more information see the Safety Policy page and the White List. Please contact the Safety Committee by emailing safety AT igem DOT org | ||
+ | </li> | ||
+ | |||
+ | <li><input type="radio" data-form-field="animal no" value="animal_no"> No </label></li> | ||
+ | |||
+ | </ul> | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | <!-------------------------------------------------------------------------------------------- Question 16 ---------------------------------------------------------------------------------------------------------> | ||
+ | |||
+ | |||
+ | |||
+ | |||
</fieldset> | </fieldset> | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
Revision as of 22:18, 28 March 2017
Final Safety Form
This form is for you to tell us all about your project, the organisms/parts you are using, the potential risks of your project, and what you are doing to reduce those risks.
- We encourage STUDENTS, instead of instructors, to complete this form. However, you will need an Instructor or PI to sign and submit this form.
- While you type, this form will remember your answers. When you are finished, press the "Submit" button at the bottom to send your form to the iGEM Safety Committee.
- Submit this form by September 1.
- If you will not be able to complete this form before the deadline, please email us (safety AT igem DOT org) and tell us about your situation.